ClinicalTrials.gg
Drug

Goserelin clinical trials

Also written Zoladex, ICI-118630 and ZOLADEX 10.8 mg.

studies test it
103
open now
17
in phase 3
34
first study started
1990

How each study uses Goserelin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Goserelin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
29 Dec 1989 · ZOLADEX · NDA 019726 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

goserelin acetate
34
Goserelin
33
ZDX
6
Goserelin (Zoladex)
3
Zoladex LA
3

Brand

Zoladex
44
ZOLADEX 10.8 mg
2
Zoladex 3.6 mg
1
ZOLADEX 3.6mg
1

Development codes

ICI-118630
4

Studies by the year they started

100 studies that test it; most in 2006 (9)

Studies that test Goserelin, by start year
YearStudies
19901
19941
19951
19971
19992
20004
20012
20032
20043
20054
20069
20075
20085
20093
20102
20112
20122
20131
20141
20155
20163
20173
20187
20193
20205
20214
20225
20234
20243
20251
20266

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
6
Phase 2
40
Phase 3
34
Phase 4
13
No phase
13

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 13 · Other 90

AstraZeneca (7) · Fudan University (5) · Radiation Therapy Oncology Group (3) · European Organisation for Research and Treatment of Cancer - EORTC (3) · City of Hope Medical Center (2) · Stanford University (2) · Eurofarma Laboratorios S.A. (2) · Novartis Pharmaceuticals (2)

Often tested with

Tested in the same studies.

Bicalutamide (16) · Leuprolide (16) · Anastrozole (10) · Letrozole (9) · Tamoxifen (7) · Degarelix (6) · Flutamide (6) · Triptorelin (6)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 8, 1 in phase 3

Studies that test Goserelin, phase 3 first.

Studies

Open first, then newest update. How each study uses Goserelin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 103

See all 103 studies that test Goserelin →

Given beside what is tested · 100 — Goserelin is usual care or a partner of the new treatment

Showing 20 of 100.

As the comparator · 23 — what is tested is compared with Goserelin

Showing 20 of 23.

Codes

What other systems call Goserelin · ClinicalTrials.gg INT008568

  • MeSH (NLM) D017273GoserelinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 0F65R8P09NGOSERELINConfirmed FDA, NLM, Wikidata
  • RxNorm 50610Confirmed FDA, Wikidata
  • Wikidata Q1992653goserelinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1374GoserelinOne source FDA
  • DrugBank DB00014One source Wikidata

Also registered as goserelin acetate (UNII 6YUU2PV0U8 · RxNorm 203146).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.